Also known as Acova
Argatroban is an anticoagulant that is a small molecule direct thrombin inhibitor. In 2000, argatroban was licensed by the Food and Drug Administration (FDA) for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). In 2002, it was approved for use during percutaneous coronary interventions in patients who have HIT or are at risk for developing it. in 2012, it was approved by the MHRA in the UK for anticoagulation in patients with Heparin-Induced Thrombocytopenia Type II( HIT) who require parenteral antithrombotic therapy.Source: Wikipedia
Patients are most commonly prescribed argatroban to treat sharp chest pain, rabies, pick disease, and west nile virus.
Patients taking argatroban most commonly experience side effects like back pain, shortness of breath, and nausea.
|Shortness of breath|
|Atrial fibrillation (AF)|
|Urinary tract infection|
|Blood in urine|
|Increased heart rate|
|Paroxysmal ventricular tachycardia (VT)|
|Heart attack (MI)|
|Decreased heart rate|
|Gastroesophageal reflux disease (GERD) (Reflux)|
|Gastrointestinal hemorrhage (GI Bleeding)|